Daily aspirin reduces risk of prostate cancer mortality

The New York Times reports, “Men treated for prostate cancer who took aspirin regularly for other medical conditions were less likely to die of their cancer than patients who weren’t taking aspirin, according to a new study published in the Journal of Clinical Oncology.”

Investigators “used the national database of a project known as CaPSURE, for Cancer of the Prostate Strategic Urologic Research Endeavor, to look at nearly 6,000 men who had localized prostate cancer and were treated with surgery or radiotherapy.”

The researchers found that “those taking aspirin were less than half as likely as those who were not to die of prostate cancer over a 10-year period, researchers calculated; the prostate cancer death rate for those taking aspirin was 3 percent, the researchers found, compared with 8 percent for those who did not.”

This entry was posted in General Health. Bookmark the permalink.